Company Description
Alimera Sciences' tunnel vision is a real asset. The biopharmaceutical company specializes in prescription ophthalmic pharmaceuticals,...
Key Alimera Financials
| Company Type | Private - NASDAQ (GM): ALIM Proposed Main Headquarters |
|---|---|
| Fiscal Year-End | December |
| 2007 Sales (mil.) | $0.0 |
| 2007 Employees | 21 |
More Alimera Financials (4 pages)
Competition
Competitive Landscape for Chemicals
Demand is driven by the health of the US economy because chemicals are used to make a wide variety of industrial and consumer products. The profitability of individual companies is closely tied to...
Read more about Alimera's competition across multiple industries
Top Alimera Competitors
Sponsored Links
The Business Directory
Alimera Executives
| Title | Name & Bio | Contact |
|---|---|---|
| President, CEO, and Director | C. Daniel Myers | Network | E-mail |
| VP and CFO | Richard S. Eiswirth Jr. | Network | E-mail |
| Chairman | Philip R. Tracy | Network | E-mail |
| Are You Listed On Hoover's? | ||
|---|---|---|
| Hoover's subscribers also get access to information on people who have self-listed with this company. Subscribers also have the option to add themselves to this company record. |
Tools from our advertising partners:
Current Alimera News
- pSivida Enters into New Evaluation for Cardiovascular Drug Delivery [Wireless News] (30 Dec 2008 00:01:00 EST)
- pSivida Enters into New Evaluation for Cardiovascular Drug Delivery [Wireless News] (29 Dec 2008 00:01:00 EST)
- Alimera Sciences Begins Pilot Study to Assess Safety and Efficacy of Iluvien(TM) in Patients With Bilateral Geographic Atrophy Due to AMD [Pain & Central Nervous System Week] (22 Dec 2008 00:01:00 EST)
Sponsored Opportunity
